Trevi Therapeutics, Inc.TRVINASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank56
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P56
Within normal range
vs 3Y Ago
-4.7x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
2025-9.95%
2024-20.23%
2023-12.40%
20222.11%
20210.30%
2020-25.67%
2019-25.22%
2018-130.96%
201728.63%
20160.00%